Across Culture and Health Systems: Argentina

  • Carlos A. VaccaroEmail author
Part of the M.D. Anderson Solid Tumor Oncology Series book series (MDA, volume 5)


Argentina is a developing country with unevenly distributed health resources and no professionals trained to perform genetic counseling for hereditary cancer. According to the available data, cancer represents a 20.7% of all causes of death and it is the second leading cause of death after cardiovascular diseases in both sexes. Colorectal cancer (CRC) is the third commonest tumor only overtaken by breast and cervical cancer uteri cancers in women, and lung and prostate cancers in men. According to the International Agency for Research on Cancer there are 10,900 new cases of colorectal cancer diagnosed each year leading to incidence rates per 100,000 of 30.1 for males and 19.1 for females As most of the countries in South America, Argentina does not have a national cancer registry. Experience in counseling for hereditary cancer is limited to the only 3 Argentine registries which are concentrated in urban centers and have a restricted scope, determined largely by the interest of individual clinicians and researchers and by resource limitations. Data from our Registry (ProCanHe) showed 79% of the individuals were aware of their risk when a close relative died from (34.5%) or were diagnosed with (44.5%) CRC. Only 1.2% was warned by a physician. Eighty-one percent of them had received surveillance recommendations. However, this occurred at a mean age of 29 years. Before counseling, up to 73% of participants had heard little or nothing about genetic testing for cancers.

In this scenario, international collaboration allowed the implementation of genetic testing with a high degree of satisfaction. In 2004, in Buenos Aires, a Regional Meeting of the Collaborative Group of the Americas on Inherited Colorectal Cancer was held with the attendance of the South American leaders. Two years later, in Sao Paulo, a South American group called “Grupo de Estudio de Tumores Hereditarios (GET) was founded on the initiative of Benedito Rossi. Currently, the first collaborative study is ongoing.

However, support for continued surveillance and counseling is still limited, which makes it difficult to appropriately run the registries.


Lynch Syndrome Colorectal cancer Developing country Health system Cancer mortality Genetic counseling Hereditary cancer registry 



The authors thank Henry T. Lynch and Paivi Peltomaki for their continued support, Esteban Langlios, MD from the Department of Internal Medicine and Plan de Salud for his help to describe the health situation section, and all the people who help to our Registry.


  1. 1.
    Dirección de Estadística e Información de la Salud (DEIS). Ministerio de Salud, INDEC:
  2. 2.
    Dirección de Estadística e Información de la Salud (DEIS);; Ministerio de Salud de la Nación, Indicadores básicos: Tabla de estadísticas vitales, Actualización 2005.
  3. 3.
    Organización Panamericana de la Salud.
  4. 4.
    World Report; “Human resources for health in the Americas”, Lancet 2007; 369: 179.Google Scholar
  5. 5.
    González García G, Tobar F. Salud para los Argentinos. Editorial Isalud 2004; 1º edición, cap. 6: 357–9.Google Scholar
  6. 6.
    González García G, Tobar F. Salud para los Argentinos. Editorial Isalud 2004; 1º edición, cap. 6: 363.Google Scholar
  7. 7.
    Dirección de Estadística e Información de la Salud (DEIS);; Ministerio de Salud de la Nación, Indicadores básicos: Tabla de recursos actualización 2005.
  8. 8.
    González García G, Tobar F. Salud para los Argentinos. Editorial Isalud, 2004; 1º edición, cap. 5: 271.Google Scholar
  9. 9.
    González García G, Tobar F. Salud para los Argentinos. Editorial Isalud, 2004; 1º edición, cap. 4: 256–7.Google Scholar
  10. 10.
    Penchaszadeh V. Genetic services in Latin America. Community Genet. 2004;7:66–8.CrossRefGoogle Scholar
  11. 11.
    Penchaszadeh VB, Beiguelman B. Medical genetics services in Latin America: report of a meeting of experts. Pan Am J Public Health. 1998;3(6):409–20.CrossRefGoogle Scholar
  12. 12.
    Goldberg PA, Madden MV, Harocopos C, et al. In a resource poor country, mutation identification has the potential to reduce the cost of family management for hereditary non-polyposis colorectal cancer. Dis Colon Rectum. 1998;41:1250–5.PubMedCrossRefGoogle Scholar
  13. 13.
    World Health Organization 1999. Prevention and care of genetic diseases and birth defects in developing countries. WHO/HGN/GL/WAOPBD/99.1.Google Scholar
  14. 14.
    World Health Organization 2000. Primary health care approaches for prevention and control of congenital and genetic disorders. WHO/HGN/WG/00.1.Google Scholar
  15. 15.
    World Health Organization 2002. Collaboration in Medical Genetics. Report of a WHO Meeting.Toronto, Canada, 9-10 April 2002. WHO/HGN/WG/02.2Google Scholar
  16. 16.
    International Agency of Research on Cancer:
  17. 17.
    Bonadeo Lassalle F, Vaccaro CA, Benati ML, Ojea Quintana G. Sindrome de Lynch: Implicancias de una patología subdignosticada. Rev Argent Cirug. 1997; 110–120Google Scholar
  18. 18.
    Raevara T, Vaccaro C, Abdel-Rahman W, et al. Pathogenicity of the Hereditary Colorrectal Mutation hLMH1 del616 linked to shortage of the functional protein. Gastroenterology. 2003;125:501–9.CrossRefGoogle Scholar
  19. 19.
    Vaccaro CA, Ardiles V, Benati M, et al. Sindrome de Lynch: Implementación ideal del diagnostico genético. Rev Argent Coloproct. 2004;15(3–4):27–33.Google Scholar
  20. 20.
    Vaccaro CA, Roverano AV, Redal MA. Hereditary Non-polyposis Colorectal Cancer. Lynch Syndrome in Argentina: Report from a Referral Hospital Register Dis Colon Rectum. 2007;50(10):1604–11.Google Scholar
  21. 21.
    Arrigoni A, Sprujevnik T, Alvisi V, et al. Clinical identification and long term surveillance of 22 hereditary non-polyposis colon cancer Italian families. Eur J Gastroenterol Hepatol. 2005;17:213–9.PubMedCrossRefGoogle Scholar
  22. 22.
    Rossi BM, Lopes A. Oliveira Ferreira F, et al. hMLH1 and hMSH2 gene mutation in Brazilian families with suspected hereditary non-polyposis colorectal cancer. Ann Surg Oncol. 2002;9(6):555–61.PubMedGoogle Scholar
  23. 23.
    Rossi BM, Corvello CM, Epelman M, et al. Hereditary colorectal tumors: routine care and the multidisciplinary therapeutic approach. S Am J Cancer. 1997;1:191–7.Google Scholar
  24. 24.
    Ferreira Oliveira F, Ferreira Napoli CC, Rossi BM, et al. Frequency of extra-colonic tumors in hereditary non-polyposis colorectal cancer (HNPCC) and familial colorectal cancer (FCC) Brazilian families. Fam Cancer. 2004;3:41–7.CrossRefGoogle Scholar
  25. 25.
    Sarroca C, Peltomaki P, Alfano N, et al. Three new mutations in hereditary non-polyposis colorectal cancer (Lynch II) in Uruguay. Cancer Genet Cytogenet. 2003;142:13–20.PubMedCrossRefGoogle Scholar
  26. 26.
    Sarroca C, Della Valle A, Fresco R, et al. Frequency of hereditary non-polyposis colorectal cancer in Uruguayan patients with colorectal cancer. Clin Genet. 2005;68:80–7.PubMedCrossRefGoogle Scholar
  27. 27.
    Fitzgibbons Jr RJ, Lynch HT, Stanislav GV, et al. Recognition and treatment of patients with hereditary non-polyposis colon Cancer (Lynch syndromes I and II). Ann Surg. 1987;206(3):289–95.PubMedCrossRefGoogle Scholar
  28. 28.
    Rodríguez-Bigas MA, Lee PH, O’ Malley L, et al. Establishment of a hereditary non-polyposis colorectal cancer registry. Dis Colon Rectum. 1996;39(6):649–53.PubMedCrossRefGoogle Scholar
  29. 29.
    Hadley DW, Jenkins J, Dimond E, et al. Genetic counseling and testing in families with hereditary non-polyposis colorectal cancer. Arch Intern Med. 2003;163:573–82.PubMedCrossRefGoogle Scholar
  30. 30.
    Wagner A, Van Kessel I, Kriege MG, et al. Long term follow up of HNPCC gene mutation carriers: compliance with screening and satisfaction with counseling and screening procedures. Fam Cancer. 2005;4(4):295–300.PubMedCrossRefGoogle Scholar
  31. 31.
    Peterson SK, Watts BG, Koehly LM, et al. How families communicates about HNPCC genetic testing: Findings from a qualitative study. Am J Med Gen. 2003;119(1):78–86.CrossRefGoogle Scholar
  32. 32.
    Suthers GK, Amstrong J, McCormack J, et al. Letting the family know: Balancing ethics and effectiveness when notifying relatives about genetic testing for a familial disorder. J Med Genet. 2006;43:665–70.PubMedCrossRefGoogle Scholar
  33. 33.
    Aktan-Collan K, Mecklin JP, de la Chapelle A, et al. Evaluation of a counselling protocol for predictive genetic testing for hereditary non-polyposis colorectal cancer. J Med Genet. 2003;37:108–13.CrossRefGoogle Scholar
  34. 34.
    Brodersen NH, Sutton S, Goff S, et al. Anticipated reactions to genetic testing for hereditary non-polyposis colorectal cancer susceptibility. Clin Genet. 2004;66(5):437–44.PubMedCrossRefGoogle Scholar
  35. 35.
    Bonadona V, Saltel P, Desseigne F, et al. Cancer patients who experienced diagnostic genetic testing for cancer susceptibility: reactions and behavior after the disclosure of a positive test result. Cancer Epidemiol Biomark Prev. 2002;11(1):97–104.Google Scholar
  36. 36.
    Collins V, Meiser B, Gaff C, et al. Screening and preventive behaviors one year after predictive genetic testing for hereditary non-polyposis colorectal carcinoma. Cancer. 2005;104(2):273–81.PubMedCrossRefGoogle Scholar
  37. 37.
    Halbert CH, Lynch H, Lynch J, et al. Colon cancer screening practices following genetic testing for hereditary non-polyposis colon cancer (HNPCC) mutations. Arch Intern Med. 2004;164(17):1881–7.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2010

Authors and Affiliations

  1. 1.Hospital Italiano deBuenos AiresArgentina

Personalised recommendations